zum Inhalt
Header Image

Personalisierte Krebsmedizin

-
Elisabeth-Herz-Kremenak-Saal
Plenary / Panel
in deutscher Sprache

Jede/r dritte EuropäerIn entwickelt im Laufe des Lebens Krebs. Weltweit sterben täglich rund 20.000 Menschen an den Folgen einer Krebserkrankung. Technologien zur Entschlüsselung des eigenen Genoms offenbaren jeder Person seine/ihre individuellen Risikofaktoren. Wieviel Aufklärung will der Mensch? Und was bieten personalisierte Krebstherapie-Ansätze?

Director, Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin
Professor emeritus, Department of Hematology-Oncology, Medical School, Johannes Gutenberg University Mainz; Co-Founder and Advisor, TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz
Director, Center of Familial Breast and Ovarian Cancer, University Clinic of Cologne
President, Helmholtz Association of German Research Centres, Berlin

Dr. med. Angelika EGGERT

Director, Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin

Medical School, University of Essen Doctoral thesis (Dr. med.), Essen Medical School with Prof. Dr. H. Esche, Dept. of Molecular Biology Resident in Pediatrics, University Children s Hospital Essen Postdoctoral Fellow (DKH + Wolfson Career Development Grant), The Children s Hospital of Philadelphia Evans Prize from the "Advances in Neuroblastoma Research" (ANR) International Symposium, Philadelphia Clinical Fellow and Junior Group Leader, Dept. of Pediatric Hematology/Oncology, University Hospital Essen Dr. Odile Schweisguth Prize from the International Society for Pediatric Oncology (SIOP) Kind-Philipp Prize for Pediatric Oncology from the German Society for Pediatric Oncology and Hematology (GPOH) Young Investigator Award, American Assoc. for Cancer Research (AACR) Senior Attending Physician (Oberärztin) and Group Leader, Dept. of Pediatric Hematology/Oncology, University Hospital Essen Habilitation in Pediatrics and Pediatric Oncology Professor of Pediatric Oncology Research (C3) and Deputy Director, Dept of Pediatric Hematology/Oncology, University Hospital Essen Head, Pediatric Cancer Research, University Hospital Essen Director, WTZ Essen (Comprehensive Cancer Center) Full Professor of Pediatrics and Director, Dept. of Pediatric Hematology and Oncology, University Hospital Essen Executive MBA in International Hospital and Health Care Management, Frankfurt School of Finance and Management Full Professor of Pediatrics and Director, Dept. of Pediatric Oncology / Hematology, Campus Virchow-Klinikum, Charité University Medicine, Berlin
1986-1993
1991-1993
1993-1997
1997-2000
1998
2000-2002
2000
2001
2001
2003-2004
2004
2004-2008
2004-2013
2007-2013
2008-2013
2009-2011
since 2013

Dr. Christoph HUBER

Professor emeritus, Department of Hematology-Oncology, Medical School, Johannes Gutenberg University Mainz; Co-Founder and Advisor, TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz

Chaired the Department of Hematology-Oncology at the Johannes Gutenberg University in Mainz. Before he was director of the Clinical Immunobiology and Stem Cell Transplantation program of the Leopold-Franzens University in Innsbruck. In Mainz he founded the Collaborative Research Centre Tumor Immunology, the Clinical Research Group Allogeneic Lymphocyte Therapy and the Interdisciplinary Immunology Program ICE.
1990-2009
 He has received his Medical Degree at the Leopold-Franzens-University in Innsbruck. He was trained in tumor immunology in the 1970ies at the Karolinska Institute in Stockholm and the Wallenberg Laboratories in Uppsala. In the early 80es he was trained in stem cell transplantation at the Fred Hutchinson Cancer Research Centre in Seattle. His preclinical and translational research foci are tumor immunology and stem cell transplantation. He has published more than 300 original articles, is editor of standard textbooks and member of the editorial boards of distinguished scientific journals. As reviewer he serves most of the leading national and many other European research foundations.

Dr. med. Rita K. SCHMUTZLER

Director, Center of Familial Breast and Ovarian Cancer, University Clinic of Cologne

Medical School University of Bonn Doctorate from the University of Bonn Assistant in Clinical Biochemistry, University of Bonn Fellowship of the German Academic Exchange Service, Reproductive Medicine at the Eastern Virginia Medical School, Norfolk, VA Foreign Medical Graduate Examination in the Medical Sciences (FMGEMS) USA Federal Licensing Examination (FLEX) USA Resident in Ob/Gyn, University Womens Hospital of Bonn Practical training course in molecular biology at the EMBL, Heidelberg Fellowship,German Research Community, Molecular Oncology, Mount Sinai Hospital New York Specialist in Ob/Gyn Habilitation fellowship of the DFG at the University of Bonn Head of the Centre for Familial Breast and Ovarian Cancer at the Universities Cologne/Bonn supported by German Cancer Aid Assistant professor at the Dept. Ob/Gyn (C2), University Womens Hospital Bonn Postdoctoral lecturing qualification (Habilitation), University of Bonn Full professor at the Dept. Ob/Gyn (C3), Div. Molecular Gyneco-Oncology, University of Cologne
1978-1984
1984
1984
1984-1985
1985
1988
1985-1992
1989
1989-1991
since 1992
1994-1997
since 1997
1998-2003
1997
since 2003

Dr. med. Dr. h.c. mult. Otmar D. WIESTLER

President, Helmholtz Association of German Research Centres, Berlin

Medical school, University of Freiburg, Germany Final medical exam, University of Freiburg, Germany Medical license, Landesärztekammer Südbaden Residency training in neuropathology, University of Freiburg MD degree, University of Freiburg Postdoctoral fellow, Department of Pathology, University of California, San Diego Residency training in neuropathology, Institute of Neuropathology, Department of Pathology, University of Zürich Senior resident in neuropathology, Institute of Neuropathology, Department of Pathology, University of Zürich / Switzerland Professor of Neuropathology, Head of the Department of Neuropathology, University of Bonn Medical Center Head, German Brain Tumor Reference Center, Bonn Member, Executive Committee, University of Bonn Medical Center Coordinator, Collaborative Research Center for Clinical & Molecular Neurobiology, University of Bonn Chairman, BONFOR research committee, University of Bonn Medical Center Elected member Pathology Board, German Research Council (DFG) Member of the Medical Advisory Board, German Cancer Aid Appointment as Head of the Department of Neuropathology, Charité Medical Center, Humboldt University Berlin (declined) President, German Society of Neuropathology and Neuroanatomy Head of the Review Board Theoretical Medicine, German Research Council Vice-Coordinator, Transregional Collaborative Research Center Mesial Temporal Lobe Epilepsies, Universities of Bonn, Berlin, Freiburg and Magdeburg 2001-2012 Review Panel Member, NCCR Neural Plasticity & Repair, Zürich Election to the German Life Science Academy Leopoldina Chief Scientific Officer, Neuroscience Technology Platform LIFE & BRAIN, University of Bonn Medical Center Chairman of the Board, Competence Network for Stem Cell Research, State of Northrhine Westfalia Chairman and Scientific Member, Management Board Deutsches Krebsforschungszentrum, Heidelberg Chairman of the Advisory Board, Deutsche Krebshilfe Member of the Executive Board, Deutsche Krebshilfe Member Board of Trustees, Meyenburg Foundation, Heidelberg Coordinator, Brain Tumor Network, National Genome Research Network 2 Member Scientific Advisory Board and Board of Trustees, German Institute for Nutrition Research, Potsdam Member Scientific Advisory Board, University Medical Center Hamburg-Eppendorf Member Board of Trustees, Heinrich F.C. Behr Foundation Member Board of Trustees, Alois Hirdt-Erben und Wieland-Stiftung Coordinator of Biomedical Research, Helmholtz Association Member Board of Trustees, Gemeinnützige Hertie-Stiftung, Frankfurt Member Board of Trustees , Hertie-Institut für Klinische Hirnforschung, Tübingen Member Board of Trustees, Georg-Speyer-Haus, Frankfurt Vice President, Helmholtz Association Member, Advisory Board Molecular Diagnostics, Siemens Medical Solutions Member, Founding Committee, German Center for Neurodegenerative Diseases Member, Scientific Committee Hansen Family Award Bayer Member, Scientific Advisory Board, Institute Gustave Roussy, Villejuif/Paris Member, International Scientific Advisory Board, INCA Paris Member, Scientific Advisory Board, Bayer Healthcare Berlin Member, Scientific Advisory Board, University of Cologne Coordinator, German Consortium for Translational Cancer Research Member of the European Academy of Tumor Immunology Member of Supervisory Board, BAYER AG Chair of SAB of National Sequencing Center President of the Helmhotz Association in Berlin
1975-1981
1981
1981
1982-1984
1984
1984-1987
1987-1989
1989-1992
1992-2003
1994-2003
1994-1999
1994-2003
1995-2003
1996-2004
1996-2004
1997
1998-1999
2000-2004
2001-2003
2001
2002-2003
2002-2003
2004-2015
2004-2014
since 2004
since 2004
2004-2010
2004-2012
2004-2008
since 2004
since 2005
2005-2012
since 2006
2007-2014
since 2007
2007-2012
2007-2011
2007-2011
since 2009
since 2010
since 2010
since 2010
since 2010
since 2011
since 2012
since 2014
since 2015
since 2015

Technologiegespräche

Timetable einblenden

25.08.2016

11:00 - 11:10EröffnungPlenary
11:10 - 12:15FTI-TalkPlenary
12:30 - 12:50Von Österreich ins Silicon Valley – Cyber-Sicherheit als globaler FaktorPlenary
12:50 - 14:10Kybernetik in modernen Energie- und ProduktionssystemenPlenary
14:30 - 15:45Komplexität und die neue AufklärungPlenary
18:00 - 18:15Best of Art and ScienceCulture
18:15 - 19:15Tickets to Berlin: Falling Walls Lab Austria and Alpbach Summer School on EntrepreneurshipPlenary
19:30 - 21:00KarriereloungeSocial
19:30 - 21:30AbendempfangSocial

26.08.2016

07:00 - 08:30Digitale MedizinPlenary
07:00 - 13:00Ö1 Kinderuni Alpbach – Wissenschaft und Technologie für KinderBreakout
07:00 - 16:00Junior Alpbach – Wissenschaft und Technologie für junge MenschenBreakout
08:30 - 10:30Cross-sektorale Kooperationen von ClusternPartner
09:00 - 10:30Personalisierte KrebsmedizinPlenary
10:30 - 11:00Imbiss für die TeilnehmerInnen der Breakout SessionsSocial
11:00 - 16:00Breakout Session 01: Innovation by Making: Paradigmenwechsel und neue InnovationskulturenBreakout
11:00 - 16:00Breakout Session 05: Zukunftstechnologie LeichtbauBreakout
11:00 - 16:00Breakout Session 08: Technologierezeption von neuen Bildungswerbenden – ein Plädoyer für transkulturelle Kompetenz als neue AufklärungBreakout
11:00 - 16:00Breakout Session 13: Standortfaktor VersorgungssicherheitBreakout
11:00 - 16:00Breakout Session 02: Silicon Austria: Ein Game-Changer für den österreichischen Hochtechnologiestandort?Breakout
11:00 - 16:00Breakout Session 04: Der Zyklus der Innovation und seine ÖkologieBreakout
11:00 - 16:00Breakout Session 06: Der Blick ins Ungewisse und die Verschiebung des HorizontsBreakout
11:00 - 16:00Breakout Session 09: Cyber Security: Ein GrundrechtBreakout
11:00 - 16:00Breakout Session 11: Robotik – Realitäten und ZukunftsperspektivenBreakout
11:00 - 16:00Breakout Session 07: Radikale Innovationen: Mehr Mut zum RisikoBreakout
11:00 - 16:00Breakout Session 10: Open Access & Open Innovation als Instrumente einer neuen Aufklärung?Breakout
11:00 - 16:00Breakout Session 12: Energiewende – die Macht der KonsumentenBreakout
11:00 - 16:00Breakout Session 03: Zukunft erfinden: Innovationsprozesse neu gestaltenBreakout
17:00 - 18:30Innovations-Marathon: Ideen auf Bestellung – 24 Stunden nonstopPlenary

27.08.2016

07:00 - 08:30Art Meets Science and Technology – Wege einer neuen AufklärungPlenary
08:45 - 09:45Open Innovation: Neue Aufklärung? Partizipation – Demokratisierung – neue LösungenPlenary
10:15 - 11:30Die ETH Zürich zu Gast bei den TechnologiegesprächenPlenary
11:30 - 12:00Imbiss zum Abschluss der VeranstaltungSocial